Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OMAB-based quadruple therapy for Helicobacter pylori eradication in Hamedan patients
IRCT138901213676N1Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of metronidazole, amoxicillin, bismuth subsalicylate and omeprazole in Helicobacter pylori infection and Peptic ulcer disease (PUD), sponsored by Hamadan University of Medical Sciences. Started Apr 2010; status: completed.
02
Drugs
metronidazoleamoxicillinbismuth subsalicylateomeprazole
03
Conditions
Helicobacter pylori infectionPeptic ulcer disease (PUD)
Beyond the preview
Go deeper on IRCT138901213676N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138901213676N1.